Abstract: An improved synthesis of a highly potent HIV reverse transcription inhibitor is disclosed, involving an acetylide and a trifluoromethyl ketone which produces a chiral product in the presence of a chiral amino alcohol.
Type:
Grant
Filed:
May 25, 1995
Date of Patent:
May 27, 1997
Assignee:
Merck & Co., Inc.
Inventors:
Andrew S. Thompson, Edward G. Corley, Edward J.J. Grabowski, Nobuyoshi Yasuda